Short Selling Rises Most Since ’06

Short Selling Rises Most Since ’06

Munshi Ahmed/Bloomberg

Short sales in New York-based Pfizer, the world’s biggest drugmaker, rose 22 percent to 111 million shares in the first two weeks of September, exchange data show.